Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...
Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...
Marlborough, Massachusetts-based Hologic already offers molecular diagnostic tests. But diagnostics companies have been looking to add multiplex offerings—the capability to identify multiple pathogens ...
The HSV testing market sees growth opportunities in advanced molecular assays, increased adoption in decentralized settings, ...
The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...
AliveDx registers MosaiQ®, its Instrument for Multiplex Testing of Autoimmune Diseases, Allergies and Beyond, as a Class II Exempt Device with the U.S. Food and Drug Administration (FDA) Provided by ...
Claims for unregulated rapid molecular diagnostic tests for urinary tract infections (UTIs) in older adults have soared 60-fold from 2016 to 2023, according to Medicare data. The rise was most ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...
Rising Allergy Prevalence and Technological Advancements Drive Market ExpansionThe Global Allergy Diagnostics Market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback